Should I increase my warfarin (Coumadin) dose because my INR is 1.9?

Should You Increase Your Warfarin Dose for an INR of 1.9?

For a single INR of 1.9 when your therapeutic target is 2.0-3.0, you should maintain your current warfarin dose without adjustment and recheck the INR in 1-2 weeks. 1

Evidence-Based Rationale for Not Adjusting

The American College of Chest Physicians specifically recommends maintaining the current dose when a single INR measurement falls ≤0.5 units below the therapeutic target (such as 1.9 when targeting 2.0-3.0). 1 This recommendation is based on moderate-quality evidence showing that:

• Single dose increases for slightly low INRs do not improve control: randomized data demonstrate that 44% of patients remained out of range after a dose change versus 40% when the dose was unchanged—essentially no benefit. 1

• Over-reacting causes "dose chasing": adjusting for isolated low values leads to greater INR instability rather than improved control. 1

• Stable patients often self-correct: in a randomized trial of 160 patients with stable anticoagulation who had an occasional out-of-range INR, 56% returned to therapeutic range at 2-week follow-up without any dose change, compared to 60% with a single-dose adjustment (not statistically different). 2

When Dose Adjustment IS Indicated

You should consider increasing your warfarin dose only if: 1

• The INR remains persistently subtherapeutic on repeat testing 1-2 weeks later
• The deviation is larger (INR consistently <1.5 for a 2.0-3.0 target)
• There is a clear explanation for the low INR (missed doses, drug interaction, dietary changes)

How to Adjust if Needed

If repeat testing confirms persistent subtherapeutic anticoagulation: 1

• Increase the total weekly dose by 5-20% rather than making daily dose changes
• Practically, this means increasing one or two daily doses by 1-2.5 mg per week
• Recheck INR 2-4 times per week after any adjustment until stability is achieved 1

Critical Context: Know Your Target Range

Your appropriate response depends entirely on your indication for anticoagulation: 3, 4

• Atrial fibrillation or venous thromboembolism: target INR 2.5 (range 2.0-3.0) 4
• Mechanical mitral valve or high-risk mechanical aortic valve: target INR 3.0 (range 2.5-3.5) 3, 4
• Recurrent thromboembolism despite therapeutic INR: target may need escalation to 2.5-3.5 or even 3.5-4.5 3

Common Pitfall to Avoid

The most important pitfall is aggressive dose escalation based on a single slightly low INR. 1, 5 Research shows that clinicians who change doses too frequently (when INR is between 1.8-3.2) achieve worse time in therapeutic range (65.8%) compared to those who only adjust when INR falls to ≤1.7 or rises to ≥3.3 (predicted 74% time in range). 5

Monitoring Schedule

After confirming your decision to maintain the current dose: 6

• Recheck INR in 1-2 weeks 1
• If stable and within range, gradually extend monitoring intervals up to every 4-12 weeks 1
• Increase monitoring frequency if you have medication changes, dietary variations, intercurrent illness, or any bleeding 6